24/7
Buzz
Startups
VC
AI
Innovation
Opinions
Events
Promising Startups 2024
BiblioTech
Boarding Pass
Corporate
Appointments
CTalk
Tech Gateways
2025 VC survey
@Finance
Ctech Testimonials
Shopping
Projects
Spotlight
About
Newsletter
Contact us
Facebook
Twitter
ACCESSIBILITY
by
Homepage
pharmaceutical
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
Innovation
OPINIONS
EVENTS
SHOPPING
ABOUT
teram of use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
14:36
Iron Dome and Iron Beam maker Rafael moves closer to a possible IPO
14:20
Weapons as strategy: Israel’s defense industry steps into a larger global role
09:09
CTech’s Book Review: What strategy really is and why so many organizations get it wrong
08:20
British Ambassador to Israel, Simon Walters: “If you build in Britain, we will back you”
More stories
Buzz
Most popular
Daily
Weekly
1
Huang declares Israel Nvidia’s “second home” with record-breaking campus investment
2
Cyera raises $400 million at $9 billion valuation in Blackstone-led round
3
Vega raises $120 million Series B as two-year-old cyber startup hits $700 million valuation
4
Dell acquires AI data-infrastructure startup Dataloop in $120 million all-cash deal
5
“The acquisition of Armis marks a clear entry by ServiceNow into cybersecurity”
More news
pharmaceutical
4 stories about pharmaceutical
Life Sciences Venture Fund aMoon Closes Second Fund at $660 Million
06.03.19
|
Hagar Ravet
The second fund will focus on mid to late-stage health companies in the domains of pharma, digital health, and medical technology
Regulation Hinders Innovative Drug Development in Israel, Executives Say
04.09.17
|
Naomi Zoreff
Despite Israel's advanced medical infrastructure, excessive red tape steers pharmaceutical companies away
Developer Of Anti-Rabies Drug Jumps on FDA Approval
27.08.17
|
Dror Reich
The plasma-derived drug is used together with the rabies vaccine to treat unvaccinated persons exposed to the virus
U.S. Congress to Investigate Rising Multiple Sclerosis Drug Prices
21.08.17
|
Dror Reich
Two Congressmen are looking into the rising MS drug prices of seven pharmaceutical companies